These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28073858)

  • 21. Fractional doses of inactivated poliovirus vaccine in Oman.
    Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
    N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.
    Bashorun AO; Badjie Hydara M; Adigweme I; Umesi A; Danso B; Johnson N; Sambou NA; Fofana S; Kanu FJ; Jeyaseelan V; Verma H; Weldon WC; Oberste MS; Sutter RW; Jeffries D; Wathuo M; Mach O; Clarke E
    Lancet Glob Health; 2022 Feb; 10(2):e257-e268. PubMed ID: 34951974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.
    Anand A; Zaman K; Estívariz CF; Yunus M; Gary HE; Weldon WC; Bari TI; Steven Oberste M; Wassilak SG; Luby SP; Heffelfinger JD; Pallansch MA
    Vaccine; 2015 Nov; 33(48):6816-22. PubMed ID: 26476367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India.
    Ahmad M; Verma H; Deshpande J; Kunwar A; Bavdekar A; Mahantashetti NS; Krishnamurthy B; Jain M; Mathew MA; Pawar SD; Sharma DK; Sethi R; Visalakshi J; Mohanty L; Bahl S; Haldar P; Sutter RW
    J Pediatric Infect Dis Soc; 2022 Feb; 11(2):60-68. PubMed ID: 34791350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.
    Cuba IPV Study Collaborative Group
    N Engl J Med; 2007 Apr; 356(15):1536-44. PubMed ID: 17429085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine.
    Nirmal S; Cherian T; Samuel BU; Rajasingh J; Raghupathy P; John TJ
    Vaccine; 1998; 16(9-10):928-31. PubMed ID: 9682339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
    Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
    Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial.
    Sutter RW; Bahl S; Deshpande JM; Verma H; Ahmad M; Venugopal P; Rao JV; Agarkhedkar S; Lalwani SK; Kunwar A; Sethi R; Takane M; Mohanty L; Chatterjee A; John TJ; Jafari H; Aylward RB
    Lancet; 2015 Dec; 386(10011):2413-21. PubMed ID: 26388534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh.
    Aziz AB; Verma H; Jeyaseelan V; Yunus M; Nowrin S; Moore DD; Mainou BA; Mach O; Sutter RW; Zaman K
    J Infect Dis; 2022 Oct; 226(8):1319-1326. PubMed ID: 35575051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization.
    Okayasu H; Sein C; Chang Blanc D; Gonzalez AR; Zehrung D; Jarrahian C; Macklin G; Sutter RW
    J Infect Dis; 2017 Jul; 216(suppl_1):S161-S167. PubMed ID: 28838185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.
    Cadorna-Carlos J; Vidor E; Bonnet MC
    Int J Infect Dis; 2012 Feb; 16(2):e110-6. PubMed ID: 22153001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
    Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
    Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial.
    John J; Giri S; Karthikeyan AS; Lata D; Jeyapaul S; Rajan AK; Kumar N; Dhanapal P; Venkatesan J; Mani M; Hanusha J; Raman U; Moses PD; Abraham A; Bahl S; Bandyopadhyay AS; Ahmad M; Grassly NC; Kang G
    J Infect Dis; 2017 Feb; 215(4):529-536. PubMed ID: 28003352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
    Embree J; Law B; Voloshen T; Tomovici A
    Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.